Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn
PSUSA/00000408/202405
Nanotechnology-based medicinal products for human use EU-IN Horizon Scanning Report
Committee for Advanced Therapies (CAT): Work Plan 2025
Human medicines European public assessment report (EPAR): Fortacin, lidocaine,prilocaine, Date of authorisation: 15/11/2013, Revision: 13, Status: Authorised
List of centrally authorised products with safety-related changes to the product information
Member states contact points for translations review
Paclitaxel (nanoparticle albumin-bound) powder for suspension for infusion, 5mg/ml
Aprepitant, hard capsules, 80mg, 125mg, 80+125mg and powder for oral suspension 125mg product-specific bioequivalence guidance
EMA/FVE webinar on veterinary prescription: conditions for using certain antimicrobials under the 'cascade', European Medicines Agency, Amsterdam, the Netherlands, from 16 January 2025, 14:00 (CET) to 16 January 2025, 15:00 (CET)